Clinical trial

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

NCT00763035

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Regadenoson Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Dobutamine Normalized identity: dobutamineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

Design: INTERVENTIONAL · Status: TERMINATED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-01-01

PhaseEARLY_PHASE1

Conditions

Coronary Artery Diseaseverified · MONDO: coronary artery disorder

Asthmaverified · MONDO: asthma

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Anginaunresolved

Interventions

RegadenosonDRUG

DobutamineDRUG · verified · RxNorm: dobutamine

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Astellas Pharma US, Inc.collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00763035 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.